Back
Tilray Brands Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
31
TLRY
Tilray Brands
Last Price:
1.73
Seasonality Move:
21.06%
Buy
59
AUPH
Aurinia Pharmaceuticals
Last Price:
7.29
Seasonality Move:
36.58%
Sell
31
Tilray Brands (TLRY)
is a Sell
Is Tilray Brands a Buy, Sell or Hold?
- The current Tilray Brands [TLRY] share price is $1.74. The Score for TLRY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- TLRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $7.16. The Score for AUPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TLRY Stock Price Chart
What is Tilray Brands's stock price today?
-
The Tilray Brands share price today is $1.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TLRY is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $7.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight selling pressure.
TLRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.78 | Sell |
| Chaikin Money Flow: | 14535180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.67 - 1.81) | Sell |
| Bollinger Bands (100): | (1.7 - 1.92) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 60.36 | Buy |
| Chaikin Money Flow: | -267788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.68 - 7.14) | Buy |
| Bollinger Bands (100): | (5.23 - 6.53) | Buy |
TLRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.74 | Sell |
| 20-day SMA: | 1.72 | Buy |
| 50-day SMA: | 1.8 | Sell |
| 200-day SMA: | 1.9 | Sell |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.74 | Sell |
| 50-day EMA: | 1.78 | Sell |
| 200-day EMA: | 1.92 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.12 | Buy |
| 20-day SMA: | 6.96 | Buy |
| 50-day SMA: | 6.3 | Buy |
| 200-day SMA: | 6.28 | Buy |
| 8-day EMA: | 7.09 | Buy |
| 20-day EMA: | 6.91 | Buy |
| 50-day EMA: | 6.48 | Buy |
| 200-day EMA: | 6.49 | Buy |
Tilray Brands Earnings Growth & TLRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.18 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.09 per share, an increase this year of $0.57 per share, and an increase next year of $0.36 per share.
Tilray Brands Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||